Navigation Links
Mayo Clinic Finds Exercise Can Reduce the Risk of Mild Cognitive Impairment
Date:4/16/2008

ROCHESTER, Minn., April 16, 2008 /PRNewswire-USNewswire/ -- A new Mayo Clinic study found that regular physical exercise may help protect against mild cognitive impairment, a disorder of the brain that affects nerve cells involved in thinking abilities. This study will be presented at the American Academy of Neurology Annual Meeting in Chicago on April 16.

Individuals with mild cognitive impairment can function reasonably well in everyday activities, but often have difficulty remembering details of conversations, events and upcoming appointments. Most (but not all) patients with mild cognitive impairment develop a progressive decline in their thinking abilities over time. Alzheimer's disease is usually the underlying cause.

"While the benefits of exercise are well documented for improving overall health, this is one of the first studies to specifically look at whether it can help protect against the development of mild cognitive impairment," says Yonas Endale Geda, M.D., a Mayo Clinic neuropsychiatrist and the study's lead investigator.

As part of the ongoing Mayo Clinic Study of Aging, Dr. Geda and a team of Mayo Clinic researchers randomly identified 868 individuals 70 to 89 years old. Of those, 128 had mild cognitive impairment and 740 were cognitively normal. The team conducted surveys to gather data on the individuals' physical exercise between the ages of 50 and 65 and one year prior to the survey. They found that moderate physical exercise two to five times per week during the ages of 50 to 65 was associated with a reduced risk of mild cognitive impairment. However, the individual's exercise habits one year prior to the survey did not appear to be associated with a reduced risk.

According to Dr. Geda, these findings need to be replicated in a prospective cohort study. Additionally, the study did not address how physical exercise could protect against mild cognitive impairment.

"Regarding the mechanism of action of physical exercise and mild cognitive impairment, we speculate that either exercise induces chemicals that protect brain cells, or exercise is simply a marker for an overall healthy lifestyle, or there is some positive interaction among exercise, healthy lifestyle and intellectually stimulating activity," says Dr. Geda.

Dr. Geda and his team will continue to follow the study participants to examine if the case-control study finding will also hold true in further studies. Other members of the Mayo Clinic research team included Rosebud Roberts, M.B.Ch.B., David Knopman, M.D., Teresa Christianson, V. Shane Pankratz, Ph.D., Bradley Boeve, M.D., Eric Tangalos, M.D., Robert Ivnik, Ph.D., Walter Rocca, M.D., and Ronald Petersen, M.D., Ph.D.

To obtain the latest news releases from Mayo Clinic, go to http://www.mayoclinic.org/news. MayoClinic.com (http://www.mayoclinic.com) is available as a resource for your health stories.


'/>"/>
SOURCE Mayo Clinic
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Research and Markets has announced the addition of the ... to their offering. ... Dermatological conditions are one of the most ... US population suffers from at least one active skin condition. ... has remained saturated with established and generic products. However, the ...
(Date:2/22/2017)... Oregon and PUNE, India , ... new report published by Allied Market Research, titled, "Radiology Information ... Global Opportunity Analysis and Industry Forecast, 2014-2022," the radiology information ... is projected to reach $941 million by 2022, growing at ... radiology information systems segment held over three-fifths share of the ...
(Date:2/22/2017)... On Tuesday, February 21, ... Average, and the S&P 500 edged higher at ... ended Tuesday,s trading session in bullish territories. Taking ... following Medical Instruments & Supplies equities this morning: ... Bard Inc. (NYSE: BCR), Glaukos Corporation (NYSE: GKOS), ...
Breaking Medicine Technology:
(Date:2/22/2017)... , ... February 22, 2017 , ... The Waismann ... the thousands of individuals who have recently fallen victim to America’s opioid epidemic. Now, ... Orange County, California, where they are free from the shame, stigma, and harmful ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... exam and eligibility requirements effective with the April 2017 testing period. NACCM, a ... , “The Care Manager Certified (CMC) exam is periodically re-calibrated to ensure that ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving ... fewer trips the emergency room, fewer hospital admissions, and better blood pressure and ... Care® (AJMC®) finds. The study can be found here . , The ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 ... doses or not filling a prescription because they could not afford to pay ... getting medications were 30-60%*. At the same time, hospitals, pharmacies, manufacturers ...
(Date:2/22/2017)... ... February 22, 2017 , ... Doctors on Liens is continuing ... ophthalmologist, Dr. Steven H. Rauchman, practicing at North Valley Eye Medical Group in ... liability, premise liability and other personal injury cases. These injuries have a major ...
Breaking Medicine News(10 mins):